Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Planned sale CHIEF OPERATING OFFICER sold 23,017 shares at $20.44 ($470,467)
  2. 4 Planned sale CHIEF FINANCIAL OFFICER sold 27,829 shares at an average $21.34 ($593,997)
  3. 4 Planned sale CHIEF FINANCIAL OFFICER sold 15,116 shares at an average $21.37 ($323,009)
  4. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 8,646 shares at $22.45 ($194,103)
  5. 4 Planned sale CHIEF OPERATING OFFICER sold 17,000 shares at $21.04 ($357,680)
  6. 4 Exercise or conversion Director acquired 1,303 shares (option exercise)
  7. 4 Planned sale CHAIRMAN & CEO sold 89,561 shares at $23.00 ($2,059,903)
  8. 4 Planned sale CHIEF OPERATING OFFICER sold 17,000 shares at $26.87 ($456,790)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 82 shares (to pay taxes)
  11. 4 Grant or award Director acquired 9,460 shares (grant or award)
  12. 4 Planned sale CHIEF OPERATING OFFICER sold 17,500 shares at $24.99 ($437,325)
  13. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 3,084 shares (to pay taxes)
  14. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 11,144 shares (to pay taxes)
  15. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,899 shares (to pay taxes)
  16. 4 Planned sale CHIEF MEDICAL OFFICER sold 60,692 shares at an average $26.12 ($1,584,991)
  17. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 3,216 shares (to pay taxes)
  18. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 68,506 shares at an average $26.12 ($1,789,190)
  19. 4 Planned sale CHIEF OPERATING OFFICER sold 17,500 shares at $26.91 ($470,925)
  20. 4 Planned sale CHAIRMAN & CEO sold 136,124 shares at an average $25.65 ($3,491,947)

Page 8 of 20 · 386 filings